Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of Affective Disorders|June 1, 2010
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended releaseMadhukar H Trivedi, David L Dunner, Susan G Kornstein, et al.
Journal of Psychiatric Research|October 26, 2005
Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trialSteven D Hollon, Richard C Shelton, Stephen Wisniewski, et al.
The American Journal of Psychiatry|May 4, 2007
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D reportMichael E Thase, Edward S Friedman, Melanie M Biggs, et al.
Clinical Trials (London, England)|November 26, 2009
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and designAndrew A Nierenberg, Louisa G Sylvia, Andrew C Leon, et al.
Depression and Anxiety|January 31, 2017
Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorderOle Köhler-Forsberg, Louisa Sylvia, Michael Thase, et al.
The American Journal of Psychiatry|January 5, 2013
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithiumAndrew A Nierenberg, Edward S Friedman, Charles L Bowden, et al.
Journal of Affective Disorders|September 8, 2014
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorderLouisa G Sylvia, Dustin J Rabideau, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|June 29, 2002
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depressionMichael E Thase, A John Rush, Rachel Manber, et al.
The American Journal of Psychiatry|May 4, 2007
Acceptability of second-step treatments to depressed outpatients: a STAR*D reportStephen R Wisniewski, Maurizio Fava, Madhukar H Trivedi, et al.
Clinical Trials (London, England)|May 30, 2014
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trialDustin J Rabideau, Andrew A Nierenberg, Louisa G Sylvia, et al.
Pageof 7